NO20020161L - Vitamin D3-analoger - Google Patents

Vitamin D3-analoger

Info

Publication number
NO20020161L
NO20020161L NO20020161A NO20020161A NO20020161L NO 20020161 L NO20020161 L NO 20020161L NO 20020161 A NO20020161 A NO 20020161A NO 20020161 A NO20020161 A NO 20020161A NO 20020161 L NO20020161 L NO 20020161L
Authority
NO
Norway
Prior art keywords
alkyl
analogues
vitamin
fluoroalkyl
hydroxyalkyl
Prior art date
Application number
NO20020161A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020161D0 (no
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Andrew David Batcho
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20020161D0 publication Critical patent/NO20020161D0/no
Publication of NO20020161L publication Critical patent/NO20020161L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20020161A 1999-07-12 2002-01-11 Vitamin D3-analoger NO20020161L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14341399P 1999-07-12 1999-07-12
PCT/EP2000/006393 WO2001004089A1 (en) 1999-07-12 2000-07-06 Vitamin d3 analogs

Publications (2)

Publication Number Publication Date
NO20020161D0 NO20020161D0 (no) 2002-01-11
NO20020161L true NO20020161L (no) 2002-01-11

Family

ID=22503954

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020161A NO20020161L (no) 1999-07-12 2002-01-11 Vitamin D3-analoger

Country Status (36)

Country Link
US (1) US6331642B1 (pl)
EP (1) EP1200399B1 (pl)
JP (1) JP3803579B2 (pl)
KR (1) KR100477161B1 (pl)
CN (1) CN1174964C (pl)
AR (1) AR024695A1 (pl)
AT (1) ATE262508T1 (pl)
AU (1) AU779408B2 (pl)
BR (1) BR0012419A (pl)
CA (1) CA2378803C (pl)
CO (1) CO5190683A1 (pl)
DE (1) DE60009303T2 (pl)
DK (1) DK1200399T3 (pl)
EG (1) EG23909A (pl)
ES (1) ES2215707T3 (pl)
GC (1) GC0000198A (pl)
HK (1) HK1047578B (pl)
HR (1) HRP20020007A2 (pl)
HU (1) HUP0202157A3 (pl)
IL (2) IL147254A0 (pl)
JO (1) JO2255B1 (pl)
MA (1) MA26808A1 (pl)
MX (1) MXPA02000313A (pl)
MY (1) MY122633A (pl)
NO (1) NO20020161L (pl)
NZ (1) NZ516339A (pl)
PE (1) PE20010328A1 (pl)
PL (1) PL201877B1 (pl)
PT (1) PT1200399E (pl)
RS (1) RS50229B (pl)
RU (1) RU2235721C2 (pl)
TR (1) TR200200054T2 (pl)
TW (1) TWI268276B (pl)
UY (1) UY26239A1 (pl)
WO (1) WO2001004089A1 (pl)
ZA (1) ZA200110487B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278744A1 (en) * 2000-08-17 2002-02-25 Chugai Seiyaku Kabushiki Kaisha Remedial agent for osteoporosis
DE60121986T2 (de) 2000-10-02 2007-07-26 Emory University Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen
RU2296121C2 (ru) * 2001-09-21 2007-03-27 Ф.Хоффманн-Ля Рош Аг Соединения, способ их получения, способы лечения
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
EP1622455A4 (en) * 2003-04-30 2009-12-16 Bioxell Spa GEMINI VITAMIN D3 COMPOUNDS AND METHOD FOR THEIR USE
US20050113348A1 (en) * 2003-06-12 2005-05-26 Yanchun Li Vitamin D and vitamin D analogs or derivatives as new anti-hypertensive agents
US20070054887A1 (en) * 2003-09-24 2007-03-08 Bioxell S.P.A Methods for treating bladder dysfunction
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
US7332482B2 (en) * 2003-09-24 2008-02-19 Bioxell S.P.A. Method for treating benign prostatic hyperplasia
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
CA2580962A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CA2586679A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
ES2544819T3 (es) * 2007-05-30 2015-09-04 Opko IP Holdings II, Inc. Proceso para la producción de precursores de la vitamina D de óxido de fosfina
TW201920257A (zh) 2008-04-11 2019-06-01 日商中外製藥股份有限公司 重複結合複數個抗原的抗原結合分子
US9018194B2 (en) * 2011-03-02 2015-04-28 Nibon University Vitamin D receptor modulators with partial agonist activity
KR102523660B1 (ko) 2016-09-26 2023-04-19 (주)하이플 박스용 테두리 부재보강부재와 에셈블리컨테이너 원터치크립이 포함된 박스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
AU708679B2 (en) 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives

Also Published As

Publication number Publication date
NO20020161D0 (no) 2002-01-11
JO2255B1 (en) 2004-10-07
ES2215707T3 (es) 2004-10-16
MY122633A (en) 2006-04-29
PE20010328A1 (es) 2001-03-22
RU2235721C2 (ru) 2004-09-10
HK1047578A1 (en) 2003-02-28
CN1360572A (zh) 2002-07-24
UY26239A1 (es) 2000-10-31
GC0000198A (en) 2006-03-29
BR0012419A (pt) 2002-03-26
IL147254A0 (en) 2002-08-14
PL201877B1 (pl) 2009-05-29
KR100477161B1 (ko) 2005-03-18
HK1047578B (zh) 2005-04-29
US6331642B1 (en) 2001-12-18
CA2378803C (en) 2009-01-27
TR200200054T2 (tr) 2002-06-21
HRP20020007A2 (en) 2003-04-30
DE60009303T2 (de) 2005-02-24
CN1174964C (zh) 2004-11-10
WO2001004089A1 (en) 2001-01-18
ZA200110487B (en) 2003-03-20
JP2003504354A (ja) 2003-02-04
CO5190683A1 (es) 2002-08-29
KR20020033728A (ko) 2002-05-07
HUP0202157A2 (en) 2002-10-28
DE60009303D1 (de) 2004-04-29
TWI268276B (en) 2006-12-11
AR024695A1 (es) 2002-10-23
DK1200399T3 (da) 2004-07-19
EG23909A (en) 2007-12-30
YU92701A (sh) 2004-09-03
EP1200399B1 (en) 2004-03-24
NZ516339A (en) 2003-07-25
PT1200399E (pt) 2004-06-30
ATE262508T1 (de) 2004-04-15
AU6689400A (en) 2001-01-30
JP3803579B2 (ja) 2006-08-02
EP1200399A1 (en) 2002-05-02
PL356124A1 (pl) 2004-06-14
AU779408B2 (en) 2005-01-20
CA2378803A1 (en) 2001-01-18
MA26808A1 (fr) 2004-12-20
RS50229B (sr) 2009-07-15
IL147254A (en) 2006-07-05
HUP0202157A3 (en) 2004-04-28
MXPA02000313A (es) 2002-06-21

Similar Documents

Publication Publication Date Title
JO2255B1 (en) Isotopes of vitamin D3
GT199900019A (es) Formulas farmaceuticamente estables de solucion de oxaliplatino.
PL341364A1 (en) 4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents
PL367682A1 (pl) Pochodne dolastatyny 10
MD1632F2 (en) Bicyclic compounds, method of inhibiting the tyrosine kinases receptors as epidermal growth factor, pharmaceutical composition, methods of preventing blastocyte implantation and treatment of mammals
YU84603A (sh) Novi inhibitori tirozin kinaze
MY132106A (en) New pyridazin-3(2h)-one derivatives
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
GB9813540D0 (en) Chemical compounds
PL361397A1 (pl) Pochodne imidazolu jako inhibitory kinazy Raf
ATE250063T1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
AU2002223058A1 (en) Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling
AU2002213421A1 (en) Condensed pyridoindole derivatives
AU2315288A (en) Cell growth inhibitors and methods of treating cancer and cell proliferative diseases
EE04777B1 (et) Kasvajavastased ühendid, neid sisaldavad farmatseutilised kompositsioonid ning nende kasutamine
MY134929A (en) Novel imidazole derivatives, production method thereof and use thereof
SE1212311T3 (pl)
MXPA02012470A (es) Inhibidores de fosfodiesterasa especificos para gmp ciclico.
PL355442A1 (pl) Analogi podstawionego homopiperydynylobenzimidazolu jako środki posiadające właściwości wiotczenia dna żołądka
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
TR199900153T2 (xx) H�cre �o�almas�n� �nlemek i�in ikame edilmi� bisindolilmaleimitler.
HK1047457A1 (zh) 皮革的鞣制
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
ATE207063T1 (de) Uracilderivate
MXPA02012165A (es) Terapia combinada contra tumores que comprende derivados de acriloil-distamicina sustituida, taxanos y/o antimetabolitos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application